Guidelines of the International Headache Society for Controlled Clinical Trials in Idiopathic Intracranial Hypertension

Mollan, Susan; Fraser, Clare; Digre, Kathleen; Diener, Hans-Christoph; Lipton, Richard; Juhler, Marianne; Pozo-Rosich, Patricia

View

Guidelines of the International Headache Society for Controlled Clinical Trials in Idiopathic Intracranial Hypertension, 2023 (924.8Kb)

Author

Mollan, Susan

Fraser, Clare

Digre, Kathleen

Diener, Hans-Christoph

Lipton, Richard

Juhler, Marianne

Pozo-Rosich, Patricia

Date

2023-08

Permanent link

https://hdl.handle.net/11351/10290

DOI

10.1177/03331024231197118

ISSN

1468-2982

PMID

37661711

Show full item record

Abstract

The quality of clinical trials is essential to advance treatment, inform regulatory decisions and meta-analysis. With the increased incidence of idiopathic intracranial hypertension and the emergence of clinical trials for novel therapies in this condition, the International Headache Society Guidelines for Controlled Clinical Trials in Idiopathic Intracranial Hypertension aims to establish guidelines for designing state-of-the-art controlled clinical trials for idiopathic intracranial hypertension.

Keywords

Idiopathic intracranial hypertension; Pseudotumor cerebri; Randomised control trial

Bibliographic citation

Mollan SP, Fraser CL, Digre KB, Diener H-C, Lipton RB, Juhler M, et al. Guidelines of the International Headache Society for Controlled Clinical Trials in Idiopathic Intracranial Hypertension. Cephalalgia. 2023 Aug;43(8):1–25.